• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

评估人类研究保护计划的质量和绩效以指导合规监督活动。

Assessing the Quality and Performance of Human Research Protection Programs to Guide Compliance Oversight Activities.

作者信息

Tsan Min-Fu, Nguyen Yen

机构信息

1 McGuire Research Institute, Richmond, VA, USA.

2 U.S. Department of Veterans Affairs, Washington, DC, USA.

出版信息

J Empir Res Hum Res Ethics. 2018 Jul;13(3):270-275. doi: 10.1177/1556264618776460. Epub 2018 May 18.

DOI:10.1177/1556264618776460
PMID:29774772
Abstract

Routine on-site reviews should focus primarily on facilities that are at risk of harming human subjects. Using human research protection program performance metric data from 107 facilities, we defined a facility to be at risk when one of its noncompliance/incident rates was among the top three highest rates of that performance metric. Based on 14 performance metrics with noncompliance and incidents in 2017, 27 facilities were identified to be at risk. These 27 facilities at risk, while constituting only 25% of all facilities, contributed to 70% ± 25% ( M ± SD; range = 32%-100%) of all reported noncompliance/incidents. Thus, performance metric data can be used to guide compliance oversight activities.

摘要

常规现场审查应主要关注那些有伤害人类受试者风险的机构。利用来自107个机构的人类研究保护计划绩效指标数据,当某个机构的违规/事件发生率在该绩效指标的最高三项发生率之中时,我们将其定义为有风险的机构。基于2017年14项存在违规和事件的绩效指标,确定了27个有风险的机构。这27个有风险的机构虽仅占所有机构的25%,却导致了所有报告的违规/事件的70%±25%(均值±标准差;范围=32%-100%)。因此,绩效指标数据可用于指导合规监督活动。

相似文献

1
Assessing the Quality and Performance of Human Research Protection Programs to Guide Compliance Oversight Activities.评估人类研究保护计划的质量和绩效以指导合规监督活动。
J Empir Res Hum Res Ethics. 2018 Jul;13(3):270-275. doi: 10.1177/1556264618776460. Epub 2018 May 18.
2
Effectiveness of Human Research Protection Program Performance Measurements.人类研究保护计划绩效评估的有效性。
J Empir Res Hum Res Ethics. 2017 Oct;12(4):217-228. doi: 10.1177/1556264617720387. Epub 2017 Jul 31.
3
Assessing the quality of human research protection programs to improve protection of human subjects participating in clinical trials.评估人类研究保护计划的质量,以加强对参与临床试验的人类受试者的保护。
Clin Trials. 2015 Jun;12(3):224-31. doi: 10.1177/1740774514568688. Epub 2015 Jan 28.
4
Improving Compliance With Institutional Review Board Continuing Review Requirements.提高对机构审查委员会持续审查要求的依从性。
J Empir Res Hum Res Ethics. 2019 Oct;14(4):365-371. doi: 10.1177/1556264619837108. Epub 2019 Mar 20.
5
Assessing the quality of VA Human Research Protection Programs: VA vs. affiliated University Institutional Review Board.评估退伍军人事务部人类研究保护项目的质量:退伍军人事务部与附属大学机构审查委员会的比较
J Empir Res Hum Res Ethics. 2013 Apr;8(2):153-60. doi: 10.1525/jer.2013.8.2.153.
6
VA residential substance use disorder treatment program providers' perceptions of facilitators and barriers to performance on pre-admission processes.美国退伍军人事务部(VA)住院物质使用障碍治疗项目提供者对入院前流程中促进因素和绩效障碍的看法。
Addict Sci Clin Pract. 2017 Apr 4;12(1):10. doi: 10.1186/s13722-017-0075-z.
7
Just-in-time IRB review: capitalizing on scientific merit review to improve human subjects research compliance.即时机构审查委员会审查:利用科学价值审查来提高人体研究的合规性。
IRB. 2005 Mar-Apr;27(2):6-10.
8
Culture of Care: Organizational Responsibilities关怀文化:组织职责
9
Oversight on the borderline: Quality improvement and pragmatic research.边缘地带的监督:质量改进与实用研究。
Clin Trials. 2015 Oct;12(5):457-66. doi: 10.1177/1740774515597682. Epub 2015 Sep 15.
10
A probability metric for identifying high-performing facilities: an application for pay-for-performance programs.一种用于识别高效设施的概率度量:在绩效付费计划中的应用。
Med Care. 2014 Dec;52(12):1030-6. doi: 10.1097/MLR.0000000000000242.

引用本文的文献

1
How Do Accredited Organizations Evaluate the Quality and Effectiveness of Their Human Research Protection Programs?认可组织如何评估其人类研究保护计划的质量和效果?
AJOB Empir Bioeth. 2023 Jan-Mar;14(1):23-37. doi: 10.1080/23294515.2022.2090641. Epub 2022 Jun 22.
2
Developing Quality and Efficiency of Institutional Review Board Review Under a Human Research Protection Program at a Leading Hospital in Central Southern China: A Descriptive Analysis of the First Three Years.中国中南部一家顶尖医院的人类研究保护计划下机构审查委员会审查的质量与效率提升:头三年的描述性分析
J Empir Res Hum Res Ethics. 2021 Jul;16(3):280-289. doi: 10.1177/1556264621995656. Epub 2021 Mar 17.